AstraZeneca

ORG Health Care / Pharmaceuticals Momentum 8.8 NORMAL Primary: Spectral Shift

$81.6B market cap (London-listed), AstraZeneca develops oncology, cardiovascular, and respiratory drugs across 100+ countries. Announced liver cancer treatment success and launched AI lung screening collaboration with Telangana health department in Q1 2026.

Active in AI-driven drug development partnerships and precision medicine collaborations. Recent claims of liver cancer treatment win; collaborating with regional health authorities on AI lung screening technology.
0.00
PSI Score
8.8
Momentum
0%
Confidence
5
Connections
Connected Entities
China Eli Lilly Sanofi Novartis Pfizer
Watch This Entity
PSI Intelligence
30-Day Trend
2026-03-20 2026-04-17 17 0 Degree Mentions
Signal Decomposition
Attention Cascade
-0.236
Narrative Drift
0.000
Spectral Shift
831.349
Sentiment-Momentum Divergence
0.000
Source Concentration
0.388
Network Analysis
5 Degree Centrality
Centrality History
2026-03-20 2026-04-17 17 0 Degree Mentions
EntityWeight StatusFirst Seen
China 4 NEW
Eli Lilly 3 NEW
Sanofi 2 NEW
Novartis 2 NEW
Pfizer 1 NEW
Article Coverage (0)
DateLaneTitle

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-04-17 ← Intelligence Network